Nutex Health (NUTX) Short term Debt (2015 - 2026)

Nutex Health has disclosed Short term Debt across 12 years of filings, most recently posting $16.7 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $16.7 million, up 22.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (up 22.68% YoY), and the FY2025 annual result was $13.3 million, down 7.36% from the prior year.
• Short term Debt came in at $16.7 million for Q1 2026 at Nutex Health, up from $13.3 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $31.4 million in Q3 2022 to a low of $2.7 million in Q1 2023.
• The 5-year median for Short term Debt is $7.9 million (2025), against an average of $9.9 million.
• Across the five-year window, Short term Debt soared 17311.83% in 2022 and slumped 89.27% in 2023, its largest moves.
• Nutex Health's Short term Debt stood at $12.5 million in 2022, then slipped by 13.85% to $10.8 million in 2023, then soared by 33.18% to $14.4 million in 2024, then dropped by 7.36% to $13.3 million in 2025, then grew by 25.43% to $16.7 million in 2026.
• The last three Short term Debt figures came in at $16.7 million (Q1 2026), $13.3 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.